Skip to main content

Table 3 Risk of all-cause, breast cancer-specific and cardiovascular mortality among Asian/Pacific Islander women compared to Non-Hispanic White women

From: Risk of cancer-specific, cardiovascular, and all-cause mortality among Asian and Pacific Islander breast cancer survivors in the United States, 1991–2011

 

Breast cancer-specific mortality

Cardiovascular mortality

All-cause mortality

Age/stage-adjusteda

Multivariable-adjustedb

Age/stage-adjusteda

Multivariable-adjustedb

Age/stage-adjusteda

Multivariable-adjustedb

HR

(95 % CI)

HR

(95 % CI)

HR

(95 % CI)

HR

(95 % CI)

HR

(95 % CI)

HR

(95 % CI)

Non-Hispanic White

Ref.

Ref.

Ref.

Ref.

Ref.

Ref.

All Asian/Pacific Islander women

0.93

(0.89–0.96)

0.88

(0.840.93)

0.76

(0.710.81)

0.77

(0.710.83)

0.86

(0.830.88)

0.82

(0.800.85)

Chinese

0.92

(0.85–0.99)

0.90

(0.83–0.99)

0.67

(0.580.77)

0.66

(0.560.78)

0.80

(0.750.84)

0.78

(0.750.84)

Japanese

0.72

(0.660.79)

0.69

(0.630.77)

0.72

(0.640.81)

0.71

(0.620.81)

0.72

(0.680.76)

0.70

(0.650.74)

Filipino

1.02

(0.96–1.08)

0.93

(0.86–1.00)

0.87

(0.78–0.99)

0.90

(0.78–1.03)

0.94

(0.90–0.99)

0.86

(0.820.92)

Hawaiian

1.20

(1.05–1.38)

1.01

(0.89–1.17)

1.65

(1.372.00)

1.43

(1.171.75)

1.30

(1.191.43)

1.09

(0.99–1.20)

Korean

0.97

(0.85–1.10)

0.89

(0.76–1.03)

0.66

(0.47–0.93)

0.68

(0.46–0.99)

0.86

(0.77–0.96)

0.80

(0.710.91)

Vietnamese

1.01

(0.88–1.16)

0.84

(0.72–0.98)

0.52

(0.350.78)

0.46

(0.280.76)

0.95

(0.85–1.06)

0.81

(0.710.92)

Asian Indian and Pakistani

0.91

(0.80–1.04)

0.85

(0.73–0.99)

0.84

(0.62–1.15)

0.98

(0.70–1.37)

0.94

(0.84–1.04)

0.91

(0.84–1.04)

Pacific Islander

1.38

(1.131.68)

1.44

(1.171.78)

1.33

(0.86–2.07)

1.33

(0.83–2.15)

1.51

(1.301.75)

1.53

(1.301.75)

Other Asian

0.80

(0.720.90)

0.95

(0.84–1.08)

0.56

(0.430.73)

0.61

(0.450.83)

0.72

(0.660.79)

0.83

(0.750.92)

  1. All estimates are for comparisons of specific Asian/Pacific Islander groups to reference group of Non-Hispanic White women. Italics indicates statistical significance at P < 0.05 after Bonferroni correction for multiple comparisons
  2. aModel with adjustment for year of diagnosis, SEER registry, age (20–49, 50–64, 65–74, 75–84, 85+ years) and AJCC stage (I, II, III)
  3. bModel with adjustment for year of diagnosis, SEER registry, age (20–49, 50–64, 65–74, 75–84, 85+ years), AJCC stage (I, II, III), birthplace (U.S., non-U.S., unknown), marital status (single or never married, married or domestic partner, unknown), hormone receptor status (ER+/PR+, ER+/PR−, ER−/PR+, ER−/PR−, unknown), tumor size (<2, ≥2 cm, unknown), lymph node status (negative, positive, unknown), surgical procedure (radical or total mastectomy, breast-conserving surgery, unspecified surgery), radiation (yes/no)